Trial of Selumetinib in Patients With Neurofibromatosis Type II Related Tumors

Conditions:   Neurofibromatosis 2;   Vestibular Schwannoma;   Meningioma;   Ependymoma;   Glioma Intervention:   Drug: Selumetinib Sponsors:   Children's Hospital Medical Center, Cincinnati;   AstraZeneca Not yet recruiting - verified March 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials